Heron Therapeutics Inc (HRTX)
2.865
+0.02
(+0.88%)
USD |
NASDAQ |
May 07, 16:00
2.865
0.00 (0.00%)
After-Hours: 16:45
Heron Therapeutics Total Long Term Debt (Quarterly): 173.75M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 173.75M |
September 30, 2023 | 173.46M |
June 30, 2023 | 149.39M |
March 31, 2023 | 149.34M |
December 31, 2022 | 149.28M |
September 30, 2022 | 149.23M |
June 30, 2022 | 149.18M |
March 31, 2022 | 149.13M |
December 31, 2021 | 149.08M |
September 30, 2021 | 149.03M |
June 30, 2021 | 148.98M |
March 31, 2021 | 7.555M |
December 31, 2020 | 7.053M |
September 30, 2020 | 6.637M |
June 30, 2020 | 6.269M |
March 31, 2020 | 5.934M |
December 31, 2019 | 5.624M |
September 30, 2019 | 5.354M |
June 30, 2019 | 5.081M |
March 31, 2019 | 4.821M |
December 31, 2018 | 4.574M |
September 30, 2018 | 4.338M |
June 30, 2018 | 29.11M |
March 31, 2018 | 28.89M |
December 31, 2017 | 28.68M |
Date | Value |
---|---|
September 30, 2017 | 28.48M |
June 30, 2017 | 28.28M |
March 31, 2017 | 53.10M |
December 31, 2016 | 52.91M |
September 30, 2016 | 52.73M |
June 30, 2016 | 2.558M |
March 31, 2016 | 2.388M |
December 31, 2015 | 2.222M |
September 30, 2015 | 2.061M |
June 30, 2015 | 1.903M |
March 31, 2015 | 1.749M |
December 31, 2014 | 1.598M |
September 30, 2014 | 1.45M |
June 30, 2014 | 1.306M |
March 31, 2014 | 1.164M |
December 31, 2013 | 1.025M |
September 30, 2013 | 0.888M |
June 30, 2013 | 0.754M |
March 31, 2013 | 0.622M |
December 31, 2012 | 0.492M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.103M |
September 30, 2011 | 0.064M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
5.081M
Minimum
Jun 2019
173.75M
Maximum
Dec 2023
91.55M
Average
149.03M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
United Therapeutics Corp | 600.00M |
Esperion Therapeutics Inc | 261.60M |
Aldeyra Therapeutics Inc | -- |
Ocular Therapeutix Inc | 74.92M |
Alpine Immune Sciences Inc | 0.00 |